Clinical pharmacogenetics implementation consortium guidelines for HLA-B genotype and abacavir dosing.

@article{Martn2012ClinicalPI,
  title={Clinical pharmacogenetics implementation consortium guidelines for HLA-B genotype and abacavir dosing.},
  author={Miguel Mart{\'i}n and Teri E. Klein and Betty J Dong and Munir Pirmohamed and David W. Haas and Deanna L. Kroetz},
  journal={Clinical pharmacology and therapeutics},
  year={2012},
  volume={91 4},
  pages={734-8}
}
Human leukocyte antigen B (HLA-B) is responsible for presenting peptides to immune cells and plays a critical role in normal immune recognition of pathogens. A variant allele, HLA-B*57:01, is associated with increased risk of a hypersensitivity reaction to the anti-HIV drug abacavir. In the absence of genetic prescreening, hypersensitivity affects ~6% of patients and can be life-threatening with repeated dosing. We provide recommendations (updated periodically at http://www.pharmkgb.org) for… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 4 times. VIEW TWEETS

From This Paper

Figures, tables, and topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 55 extracted citations

ADME Processes in Pharmaceutical Sciences

Springer International Publishing • 2018

Genomics of Adverse Drug Reactions.

Trends in pharmacological sciences • 2017

HLA Association with Drug-Induced Adverse Reactions

Journal of immunology research • 2017
View 3 Excerpts

References

Publications referenced by this paper.
Showing 1-10 of 46 references

2010 ESF-UB Conference on Pharmacogenetics and Pharmacogenomics

Becquemont, L. et al. Practical recommendations for pharmacogenom prescription
Pharmacogenomics 12, 113–124 • 2011

Panel on Antiretroviral Guidelines for Adults and Adolescents . Guidelines for the Use of Antiretroviral Agents in HIV1infected Adults and Adolescents

L. Becquemont
Department of Health and Human Services • 2011

from bench to byte–an update of guidelines

Swen, J. J. et al. Pharmacogenetics
Clin. Pharmacol. Ther. 89, 662–673 • 2011

models of T-cell stimulation

J. Adam, W. J. Pichler, Yerly, D. Delayed drug hypersensitivity
Br. J. Clin. Pharmacol. 71, 701–707 • 2011

Similar Papers

Loading similar papers…